Riverside Healthcare - Screening and Risk Assessment Program
Find a Doctor Employees Healthcare Professionals Newsroom

Screening and Risk Assessment Program Print Friendly and PDF

The objective of the Riverside Healthcare Screening and Risk Assessment Program is to empower, educate and provide resources to patients who may be at increased for specific cancers and would benefit from a thorough risk assessment and possibly genetic testing. The National Comprehensive Cancer Network, US Preventative Services Task Force, and American College of Obstetrics and Gynecology have specific guidelines regarding referral for genetic counseling based on family history for a number of different settings. Individuals found to have hereditary cancer or cancer predisposition are candidates for increased surveillance and prevention options. The Riverside Healthcare Screening and Risk Assessment Program will incorporate these guidelines into personalized care plans for each patient.

Julie Sieling, CNP
Riverside Healthcare Screening and Risk Assessment Program

"Knowledge is power, and knowing your own story is half the battle," said Julie Sieling, CNP, Riverside Breast Center Nurse Practitioner and team member of the Riverside Healthcare Screening and Risk Assessment Program. “This program is designed to assist people with a strong personal or family history of cancer better understand their own risk of developing hereditary cancers and allows them to be more empowered in their healthcare decisions based on the benefits of genetic testing."

Julie helps to guide patients every step of the way. From helping patients complete the initial risk assessment to discussing the benefits and limitations of genetic testing to interpreting results and providing recommendations, education, and follow-up, Julie’s role is to help guide patients along their Screening and Risk Assessment journey. She’s there to answer any questions that may arise and help to empower patients in making more informed healthcare choices.

Who may benefit from a thorough risk assessment?

A simple, 2-minute questionnaire will be offered to all patients at their annual mammography appointment. The questionnaire is used to gather the information needed to discuss individual cancer risk and determine if there are any red flags in the patient’s personal or family health history. Red flags include:

After the questionnaire is completed, the patient will then view a 5-minute educational video and speak with a genetic counselor via phone. He or she may then elect to have testing drawn immediately or at a later time.

What does the myRisk Hereditary Cancer Panel test include?

The myRisk Hereditary Cancer Panel consists of up to 28 genes that impact personalized inherited risks for eight cancers, including:

When will the myRisk Hereditary Cancer Panel test results be available?

The patient’s panel is typically available in 3 to 4 weeks, at which time the Breast Center Nurse Practitioner meets personally with each patient to counsel and discuss the findings, next steps, recommendations and management plans. A copy of the results, along with national guideline recommendations, will be shared with the patient’s provider and included in the patient’s electronic medical record to assist in further screening management for high risk patients. Patients who desire or are in need of referrals to specialists or additional resources will have the guidance and support provided by the team at Riverside to help navigate the network of comprehensive services and programs available at Riverside Healthcare and beyond.

What is the cost?

The cost of genetic testing varies depending on the patient’s insurance or Medicare coverage. Myriad, the myRisk Hereditary Cancer Panel genetics laboratory, will verify each patient’s insurance coverage before running the test and contact the patient to notify of the amount that may be owed prior to starting the test. The test will only be completed upon authorization from the patient.

Points of entry into the Riverside Healthcare Screening and Risk Assessment Program:

Contact Information

For more information about the Screening and Risk Assessment Program at Riverside Healthcare contact Julie Sieling, CNP at 779-701-2777.